Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
34,01 USD | +7,19 % | -4,17 % | -5,26 % |
Métier
Nombre d'employés: 103 605
Ventes par activité
CHF en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Pharmaceuticals
76,6
%
| 48 628 | 73,2 % | 46 279 | 76,6 % | -4,83 % |
Diagnostics
23,4
%
| 17 798 | 26,8 % | 14 162 | 23,4 % | -20,43 % |
Ventes par région
CHF en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
46,9
%
| 29 313 | 44,1 % | 28 352 | 46,9 % | -3,28 % |
Rest of Europe
16,1
%
| 10 328 | 15,5 % | 9 703 | 16,1 % | -6,05 % |
Rest of Asia
14,7
%
| 9 852 | 14,8 % | 8 890 | 14,7 % | -9,76 % |
Japan
7,4
%
| 6 452 | 9,7 % | 4 464 | 7,4 % | -30,81 % |
Latin America
4,9
%
| 2 870 | 4,3 % | 2 971 | 4,9 % | +3,52 % |
Germany
4,8
%
| 3 318 | 5,0 % | 2 893 | 4,8 % | -12,81 % |
Africa, Australia and Oceania
2,0
%
| 1 520 | 2,3 % | 1 212 | 2,0 % | -20,26 % |
Switzerland
1,8
%
| 1 671 | 2,5 % | 1 118 | 1,8 % | -33,09 % |
Rest of North America
1,4
%
| 1 102 | 1,7 % | 838 | 1,4 % | -23,96 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 49 | 01/01/03 | |
Severin Schwan
CHM | Chairman | 57 | 01/01/08 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 01/04/11 |
Pascale Schmidt
CMP | Compliance Officer | 51 | 01/01/20 |
Levi Garraway
CTO | Chief Tech/Sci/R&D Officer | - | - |
Bruno Eschli
IRC | Investor Relations Contact | - | - |
Silke Hörnstein
PRN | Corporate Officer/Principal | 49 | 01/01/15 |
Annette Luther
SEC | Corporate Secretary | 54 | 01/04/20 |
General Counsel | 60 | 01/04/20 | |
Human Resources Officer | 57 | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 03/03/15 |
Director/Board Member | 59 | - | |
Director/Board Member | 66 | 01/01/96 | |
Patrick Frost
BRD | Director/Board Member | 56 | 17/03/20 |
Hans Clevers
PRN | Corporate Officer/Principal | 67 | 05/03/19 |
Severin Schwan
CHM | Chairman | 57 | 01/01/08 |
Anita Hauser
BRD | Director/Board Member | 55 | 14/03/17 |
Director/Board Member | 71 | 03/03/15 | |
Director/Board Member | 58 | 01/03/16 | |
Joerg Duschmale
BRD | Director/Board Member | 40 | 17/03/20 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 106 691 000 | 28 989 189 ( 27,17 %) | 0 | 88,91 % |
Action B | 1 | 702 562 700 | 690 549 674 ( 98,29 %) | 12 011 755 ( 1,710 %) |
Participations
Nom | Actions | % | Valorisation |
---|---|---|---|
1 005 670 000 | 59,89% | 30 596 634 817 $ | |
ROCHE HOLDING AG 1,43% | 10 073 029 | 1,43% | 2 579 249 239 $ |
2 744 120 | 7,42% | 42 451 536 $ | |
454 961 | 3,02% | 11 810 788 $ | |
ALIGOS THERAPEUTICS, INC. 14,70% | 11 025 941 | 14,70% | 6 505 305 $ |
1 893 | 0,06% | 1 609 $ |
Coordonnées société
Sociétés du groupe
Nom | Catégorie et Secteur |
---|---|
Viewics India Pvt Ltd.
| |
Roche Financial Investments Ltd.
| |
Roche Diagnostics Belgium NV
Roche Diagnostics Belgium NV BiotechnologyHealth Technology Part of Roche Holding AG, Roche Diagnostics Belgium NV is a Belgian company that develops innovative products and services for the prevention, diagnosis, monitoring, screening, and treatment of diseases. Roche Diagnostics Belgium is based in Diegem, Belgium, and was founded in 1958. The company offers next-generation sequencing products and in vitro diagnostics that are an integral part of decision-making along the entire continuum of a patient's health or disease. The CEO is Thomas Schinecker. |
Biotechnology
|
Roche Finance Europe BV
|
Finance/Rental/Leasing
|
Roche Financial Management Ltd.
| |
Roche Catalyst Investments Ltd.
| |
Roche Intertrade Ltd.
| |
Roche Pharmholding BV
Roche Pharmholding BV Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharmholding BV is a Dutch company that manufactures and distributes pharmaceutical and vitamin products. The company is based in Woerden, Netherlands. |
Medical Distributors
|
Sapac Corp. Ltd.
|
Secteur
Ventes par activité
Ventes par région
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+55,32 % | 815 Md | |
+44,05 % | 641 Md | |
-6,75 % | 352 Md | |
+13,56 % | 314 Md | |
+10,68 % | 303 Md | |
+16,57 % | 242 Md | |
+13,31 % | 218 Md | |
+8,48 % | 168 Md | |
-2,81 % | 159 Md |
- Bourse
- Actions
- Action ROG
- Action 0TDF
- Société Roche Holding AG